Clinical trials
Encephalitis, Tick-Borne trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 5 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 5 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 7 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 19 |
| University Medical Centre Ljubljana | 7 |
| Medical University of Vienna | 3 |
| Novartis | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Sormland County Council, Sweden | 2 |
| University Hospital, Strasbourg, France | 2 |
| Charles University, Czech Republic | 1 |
| Elisabethinen Hospital | 1 |
| Giuseppe Pantaleo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Encephalitis, Tick-Borne | 50 |
| Brucellosis | 2 |
| Chikungunya Fever | 2 |
| Encephalitis | 2 |
| Hepatitis E | 2 |
| Leishmaniasis | 2 |
| Leptospirosis | 2 |
| Lyme Disease | 2 |
| Q Fever | 2 |
| Tick Bites | 2 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.